Rani Therapeutics (RANI) Competitors $0.49 +0.01 (+1.24%) Closing price 10/15/2025 04:00 PM EasternExtended Trading$0.50 +0.01 (+1.14%) As of 07:48 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock RANI vs. BHST, APLT, FATE, IVVD, ONCY, CLYM, HURA, TVGN, OVID, and ATOSShould you be buying Rani Therapeutics stock or one of its competitors? The main competitors of Rani Therapeutics include BioHarvest Sciences (BHST), Applied Therapeutics (APLT), Fate Therapeutics (FATE), Invivyd (IVVD), Oncolytics Biotech (ONCY), Climb Bio (CLYM), TuHURA Biosciences (HURA), Tevogen Bio (TVGN), Ovid Therapeutics (OVID), and Atossa Genetics (ATOS). These companies are all part of the "pharmaceutical products" industry. Rani Therapeutics vs. Its Competitors BioHarvest Sciences Applied Therapeutics Fate Therapeutics Invivyd Oncolytics Biotech Climb Bio TuHURA Biosciences Tevogen Bio Ovid Therapeutics Atossa Genetics BioHarvest Sciences (NASDAQ:BHST) and Rani Therapeutics (NASDAQ:RANI) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their profitability, earnings, risk, institutional ownership, valuation, analyst recommendations, dividends and media sentiment. Which has more risk & volatility, BHST or RANI? BioHarvest Sciences has a beta of 0.78, meaning that its share price is 22% less volatile than the S&P 500. Comparatively, Rani Therapeutics has a beta of -0.02, meaning that its share price is 102% less volatile than the S&P 500. Does the media refer more to BHST or RANI? In the previous week, BioHarvest Sciences had 1 more articles in the media than Rani Therapeutics. MarketBeat recorded 2 mentions for BioHarvest Sciences and 1 mentions for Rani Therapeutics. Rani Therapeutics' average media sentiment score of 0.95 beat BioHarvest Sciences' score of 0.83 indicating that Rani Therapeutics is being referred to more favorably in the news media. Company Overall Sentiment BioHarvest Sciences Positive Rani Therapeutics Positive Is BHST or RANI more profitable? Rani Therapeutics has a net margin of 0.00% compared to BioHarvest Sciences' net margin of -39.95%. Rani Therapeutics' return on equity of -1,258.76% beat BioHarvest Sciences' return on equity.Company Net Margins Return on Equity Return on Assets BioHarvest Sciences-39.95% -11,357.84% -39.94% Rani Therapeutics N/A -1,258.76%-97.97% Do analysts recommend BHST or RANI? BioHarvest Sciences presently has a consensus target price of $13.67, suggesting a potential upside of 8.04%. Rani Therapeutics has a consensus target price of $7.33, suggesting a potential upside of 1,395.38%. Given Rani Therapeutics' higher probable upside, analysts clearly believe Rani Therapeutics is more favorable than BioHarvest Sciences.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score BioHarvest Sciences 1 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.50Rani Therapeutics 1 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.50 Do institutionals and insiders hold more shares of BHST or RANI? 30.2% of Rani Therapeutics shares are held by institutional investors. 45.1% of Rani Therapeutics shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term. Which has preferable earnings & valuation, BHST or RANI? BioHarvest Sciences has higher revenue and earnings than Rani Therapeutics. BioHarvest Sciences is trading at a lower price-to-earnings ratio than Rani Therapeutics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBioHarvest Sciences$25.19M8.25-$12.91M-$0.70-18.07Rani Therapeutics$1.03M34.22-$30.02M-$0.91-0.54 SummaryRani Therapeutics beats BioHarvest Sciences on 8 of the 14 factors compared between the two stocks. Get Rani Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for RANI and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding RANI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart RANI vs. The Competition Export to ExcelMetricRani TherapeuticsMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$34.81M$3.36B$6.12B$10.45BDividend YieldN/A2.30%5.73%4.77%P/E Ratio-0.5422.7785.3327.36Price / Sales34.22486.46601.99136.95Price / CashN/A46.7037.4661.86Price / Book8.1710.5512.566.81Net Income-$30.02M-$52.58M$3.32B$276.80M7 Day Performance2.77%0.09%0.59%0.42%1 Month Performance-1.72%15.61%10.52%7.86%1 Year Performance-81.14%15.13%75.05%41.24% Rani Therapeutics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)RANIRani Therapeutics3.337 of 5 stars$0.49+1.2%$7.33+1,395.4%-76.9%$34.81M$1.03M-0.54110BHSTBioHarvest Sciences1.6722 of 5 stars$9.85+12.3%$13.67+38.7%N/A$144.05M$25.19M-14.07N/AGap UpHigh Trading VolumeAPLTApplied Therapeutics3.8388 of 5 stars$1.02+2.0%$4.13+304.4%-86.3%$144.01M$121K-2.2730News CoverageAnalyst ForecastFATEFate Therapeutics3.8967 of 5 stars$1.41+16.5%$3.30+134.0%-49.8%$139.55M$13.63M-0.97550High Trading VolumeIVVDInvivyd3.5371 of 5 stars$1.42+22.4%$5.14+261.8%+84.0%$139.37M$25.38M-1.54100Gap UpHigh Trading VolumeONCYOncolytics Biotech1.9531 of 5 stars$1.36-1.4%$5.00+267.6%-2.4%$138.50MN/A-5.0430Gap UpCLYMClimb Bio4.1414 of 5 stars$1.81-8.6%$9.25+411.0%N/A$134.17MN/A-2.599Trending NewsAnalyst ForecastAnalyst RevisionHURATuHURA Biosciences1.573 of 5 stars$2.49-4.2%$12.67+408.7%N/A$132.87MN/A0.00N/ATVGNTevogen Bio2.8464 of 5 stars$0.65-3.7%$10.00+1,441.3%-44.9%$132.56MN/A-3.413News CoverageOVIDOvid Therapeutics4.5389 of 5 stars$1.79-2.7%$3.10+73.2%+43.5%$130.84M$6.65M-3.3860ATOSAtossa Genetics2.6138 of 5 stars$1.00-1.0%$6.25+525.0%-26.6%$130.46MN/A-4.358News CoverageAnalyst Downgrade Related Companies and Tools Related Companies BHST Alternatives APLT Alternatives FATE Alternatives IVVD Alternatives ONCY Alternatives CLYM Alternatives HURA Alternatives TVGN Alternatives OVID Alternatives ATOS Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:RANI) was last updated on 10/16/2025 by MarketBeat.com Staff From Our PartnersURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredOctober 16 Changes the Microchip Game — and InvestingWhile everyone's chasing the same AI plays, George Gilder is focused on something completely different. He ...Banyan Hill Publishing | SponsoredGenerate up to $5,000/month with 10X less money?The secret to retiring without a million-dollar nest egg. I'm talking about generating enough monthly inco...Investors Alley | SponsoredNEW LAW: Congress Approves Setup For Digital Dollar?Trump Ally Says Congress Approved the Setup for a Digital Dollar 2.0 But according to Rep. Marjorie Taylor ...Goldco Precious Metals | SponsoredElon’s Out 🚫. Trump’s DOGE Payouts Keep Flowing (Up to $32K a Year)DOGE payouts are already moving. Every 90 days, billions flow out — whether you’ve claimed your share or not. ...Angel Publishing | SponsoredGold to $27,533?This week, U.S. gold reserves hit an unprecedented $1 TRILLION in value... And it's sparking urgent chatter...Stansberry Research | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…A Millionaire With SEVEN Clicks? $1,000 in just seven stocks in 2004 could have turned into a million-dolla...The Oxford Club | SponsoredShots officially fired…Elon Musk just declared war on the wireless giants with a $17 billion spectrum deal that gives SpaceX the righ...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Rani Therapeutics Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Rani Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
